Colorectal Cancer Trial, Recruiting NCT05224518 Sponsor: National Taiwan University Hospital Hsin-Chu Branch Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05224518
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 21 or older who have been diagnosed with colorectal cancer at an early to non-spreading stage (in situ, Stage I, II, or III)
  • People who are mentally well and able to think clearly
  • People who are able to read or speak Mandarin or Taiwanese, as the study materials are in these languages
  • People who have agreed to take part by signing a consent form
  • People who do not have any physical disabilities

Who may not be able to join:

  • People who currently have swelling or inflammation in their arms, legs, or joints
  • People who have had abdominal (belly) surgery in the past 3 months
  • People who have active heart or blood vessel problems causing symptoms
  • People who have been taking antidepressant medication over a long period of time
  • People who have limited movement or use of one arm or one leg
  • People who have regularly done moderate or vigorous exercise for more than six months
  • People who have a colostomy or ileostomy (a surgically created opening in the abdomen for waste to leave the body)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hui-Mei Chen, University of Nursing and Health Sciences, Taipei, Taiwan

Phone: 0917741835

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Taiwan University Hospital Hsin-Chu Branch
Registry
ClinicalTrials.gov
Start date
21 February 2022
Est. completion
31 December 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Quality of life of cancer patients(EORTC QLQ-C30); Quality of life of cancer patients(EORTC QLQ-C30); Quality of life of cancer patients(EORTC QLQ-C30); Quality of life of cancer patients(EORTC QLQ-C30); Quality of life of cancer patients(EORTC QLQ-C30); Quality of life of cancer patients(EORTC QLQ-C30); Quality of life of cancer patients(EORTC QLQ-C30); Quality of life of cancer patients(EORTC QLQ-CR29); Quality of life of cancer patients(EORTC QLQ-CR29); Quality of life of cancer patients(EORTC QLQ-CR29); Quality of life of cancer patients(EORTC QLQ-CR29); Quality of life of cancer patients(...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov